Enhancing oncolytic virotherapy with a tri-specific T-cell engager targeting CD3ε, EpCaM, and 4-1BB: preclinical evaluation and implications for cancer immunotherapy.

Further analysis of peritoneal metastatic tumors showed that Ad5-TriTE treatment led to a reduction in both the number and weight of metastatic nodules compared to PBS-treated mice, although the differences did not reach statistical significance due to intergroup variability.

also in 111,027 other papers